Novonesis delivered strong start to the year with 7% organic sales growth in Q1

COPENHAGEN, Denmark – May 5, 2026. In the first quarter of 2026, Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA margin of 37.8%. Ester Baiget, President & CEO: “The year started strong with 7% organic sales growth against a high comparable. We delivered growth across all sales areas and in both Developed and Emerging markets, while achieving an adjusted EBITDA margin of 37.8%. Quarter after quarter, our results demonstrate the strength and resilience of our business model. Even with increased global uncertainty, we are confident in our full-year outlook and in our 2030 targets, including a 6–9% organic sales growth CAGR. As the world continues to change, the relevance and demand for biosolutions continue to grow." Highlights of our Q1 2026 results: • Strong broad-based organic sales growth of 7% including ~1.5 pp effect from exiting certain countries. Price and revenue synergies contributed ~1 pp each. • Food & Health Biosolutions grew 9% organically including ~3 pp effect from exiting certain countries; Planetary Health Biosolutions grew 5% organically. • Developed Markets grew 8% organically and Emerging Markets 4% including ~3 pp effect from exiting certain countries. • Adjusted EBITDA margin at 37.8% including a significant year-on-year currency headwind. • Adjusted net profit excl. PPA increased 8%. • NIBD/EBITDA at 2.0x, and free cash flow before acquisitions increased 9% to EUR 74 million. CAPEX ratio at 8.3%. • Successful inaugural bond issuance of EUR 1.7 billion completed to refinance a bridge loan facility. • Acquisition of a production facility in Thailand to support growth journey. • 2026 outlook confirmed: Organic sales growth is expected to be in the range of 5-7% which includes a close to 1 pp effect from exiting certain countries. Adjusted EBITDA margin expected to be between 37-38%. Here is the link to the investor call on Novonesis Q1 2026 results: https://getvisualtv.net/stream/?novonesis-interim-report-q1-2026 Get in touch Media relations Benjamin Hjorth Senior Press Manager media-relations@novonesis.com +45 30 77 13 12 Tobias Bjorklund Head of Investor Relations tobb@novonesis.com